Lv2
110 积分 2025-11-13 加入
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
4个月前
已完结
Population Pharmacokinetics of Efsubaglutide Alfa in Healthy Subjects and Subjects with Type 2 Diabetes
8个月前
已完结
Safety, pharmacokinetics and pharmacodynamics of Efsubaglutide Alfa in healthy participants: A randomised, dose‐escalation phase 1 study
8个月前
已完结
Efficacy and safety of Efsubaglutide Alfa in “overrun” patients in the SUPER2 trial: A post‐hoc analysis for comprehensive evaluation
8个月前
已完结
Exposure–Response Analysis of Efsubaglutide Alfa in Patients with Type 2 Diabetes Treated with Metformin
8个月前
已完结
Biweekly dosing of efsubaglutide alfa maintains glycaemic and continuous glucose monitoring control in type 2 diabetes: A randomised multicentre trial
8个月前
已完结
Validation of Clinical Dynamic Contrast-Enhanced Magnetic Resonance Imaging Perfusion Modeling and Neoadjuvant Chemotherapy Response Prediction in Breast Cancer Using 18 FDG and 64 Cu-DOTA-Trastuzumab Positron Emission Tomography Studies
在EXCEL中实现多总体方差的Bartlett齐性检验
皖公网安备34019202002308
